Diagnosis and Treatment of Lung Neuroendocrine Neoplasms Somatostatin Receptor PET Imaging and Peptide Receptor Radionuclide Therapy

被引:2
|
作者
Park, Hyesun [1 ]
Subramaniam, Rathan M. [2 ,3 ]
机构
[1] Lahey Hosp, Med Ctr, Dept Radiol, 41 Burlington Mall Rd, Burlington, MA 01850 USA
[2] Univ Otago Sch Med, Dept Med, 01 Great King St, Dunedin 9016, New Zealand
[3] Duke Univ, Dept Radiol, Davison Bldg, Durham, NC 27710 USA
关键词
Lung carcinoid; Somatostatin receptor PET imaging; Peptide receptor radionuclide therapy; CARCINOID TUMORS; PULMONARY; SURVIVAL; EFFICACY; LU-177-DOTATATE; EVEROLIMUS; RADIANT-4; CONSENSUS; SPECT/CT;
D O I
10.1016/j.cpet.2022.11.005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[No abstract available]
引用
收藏
页码:223 / 231
页数:9
相关论文
共 50 条
  • [1] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors with somatostatin analogues
    Bodei, L.
    Pepe, G.
    Paganelli, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2010, 14 (04) : 347 - 351
  • [2] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
  • [3] Somatostatin receptor radionuclide therapy in neuroendocrine tumors
    Haider, Mintallah
    Das, Satya
    Al-Toubah, Taymeyah
    Pelle, Eleonora
    El-Haddad, Ghassan
    Strosberg, Jonathan
    [J]. ENDOCRINE-RELATED CANCER, 2021, 28 (03) : R81 - R93
  • [4] SOMATOSTATIN RECEPTOR IMAGING IN THE DIAGNOSIS AND TREATMENT OF NEUROENDOCRINE TUMORS
    LAMBERTS, SWJ
    REUBI, JC
    KRENNING, EP
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1992, 43 (1-3): : 185 - 188
  • [5] ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
    Hicks, Rodney J.
    Kwekkeboom, Dik J.
    Krenning, Eric
    Bodei, Lisa
    Grozinsky-Glasberg, Simona
    Arnold, Rudolf
    Borbath, Ivan
    Cwikla, Jaroslaw
    Toumpanakis, Christos
    Kaltsas, Greg
    Davies, Philippa
    Hoersch, Dieter
    Tiensuu Janson, Eva
    Ramage, John
    [J]. NEUROENDOCRINOLOGY, 2017, 105 (03) : 295 - 309
  • [6] Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment
    Pignata, Salvatore Antonio
    Ferrantelli, Andrea
    Baldari, Sergio
    [J]. CLINICAL AND TRANSLATIONAL IMAGING, 2019, 7 (05) : 373 - 376
  • [7] Peptide receptor radionuclide therapy plus somatostatin analogues for a neuroendocrine tumour combined and maintenance treatment
    Salvatore Antonio Pignata
    Andrea Ferrantelli
    Sergio Baldari
    [J]. Clinical and Translational Imaging, 2019, 7 : 373 - 376
  • [8] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    [J]. NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [9] Initial experience with somatostatin receptor (SSTR) imaging and peptide receptor radionuclide therapy for patients with neuroendocrine differentiation (NED) of prostate cancer
    Assadi, M.
    Rekabpour, S.
    Ahmadzadehfar, H.
    Jafari, E.
    Amini, A.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S696 - S697
  • [10] Somatostatin Receptor Imaging PET in Neuroendocrine Neoplasm
    Johnbeck, Camilla Bardram
    Mortensen, Jann
    [J]. PET CLINICS, 2021, 16 (02) : 191 - 203